Table 1 General characteristics and baseline clinicopathological features of DLBCL patients
Variables | DLBCL n = 36 (%) | |
|---|---|---|
Age median (range) | 62 (23–83) | |
Gender males/females | 20/16 | |
Ann-Arbore stage | I-II | 9 (25) |
III-IV | 27 (75) | |
IPI | Low (0–1) | 8 (22) |
Medium (2–3) | 15 (42) | |
High (4–5) | 13 (36) | |
LDH | Normal | 18 (50) |
High | 18 (50) | |
Ki-67 | <  70% | 15 (42) |
≥ 70% | 21 (58) | |
Cell of origin | GC | 22 (61) |
Non-GC | 10 (28) | |
NE | 4 (11) | |
Translocations (§) | None | 10 (28) |
Single | 10 (28) | |
Double hit | 4 (11) | |
NE | 12 (33) | |
Response to treatment (^) | ORR | 27 (84) |
CRR | 24 (75) | |
Primary refractory | 5 (15) | |